An evaluation of the history of a marijuana withdrawal syndrome in a large population.
paper
Primary
Public
Unavailable
- Authors
- Wiesbeck, G A; Schuckit, M A; Kalmijn, J A; Tipp, J E; Bucholz, K K; Smith, T L
- Year
- 1996
- Journal
- Addiction (Abingdon, England)
- PMID
- 8917915
Case reports and laboratory research indicate the existence of a cannabis withdrawal syndrome. However, the data tell us little about the prevalence and clinical characteristics of a marijuana withdrawal syndrome in people who have used the drug but who did not enter treatment for cannabis dependence. Face-to-face semi-structured interviews applying standard diagnostic criteria were used in the present study to gather data from 5611 men and women, recruited between 1991 and 1995 through the Collaborative Study of the Genetics of Alcoholism (COGA). Almost 41% of the sample had no history of marijuana use (Group 1), 28% had consumed this drug less than 21 times in any single year (Group 2), and 31% used it at least that frequently (Groups 3 and 4). Almost 16% of the more frequent marijuana users related a history of a marijuana withdrawal syndrome, and these Group 4 subjects had used the drug almost daily for an average of almost 70 months. The typical withdrawal symptoms included "nervous, tense, restlessness", "sleep disturbance" and "appetite change". While Group 4 subjects were more likely to have developed dependence on most types of drugs, even when alcohol and drug use patterns were statistically taken into account, marijuana use was still significantly related to a self-report of a history of marijuana withdrawal.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors. | Brunetti P et al. | β | 2020 | β |
| Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. | Bahji A et al. | β | 2020 | β |
| Sex and Strain Variation in Initial Sensitivity and Rapid Tolerance to Ξ9-Tetrahydrocannabinol. | Parks C et al. | β | 2020 | β |
| Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions. | Choi S et al. | β | 2020 | β |
| DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. | Livne O et al. | β | 2019 | β |
| Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis. | Kassai S et al. | β | 2017 | β |
| The cannabis withdrawal syndrome: current insights. | Bonnet U et al. | β | 2017 | β |
| Cannabis withdrawal and sleep: A systematic review of human studies. | Gates P et al. | β | 2016 | β |
| Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults. | Ganzer F et al. | β | 2016 | β |
| Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum. | Bonnet U et al. | β | 2014 | β |
| Cannabis withdrawal in patients with and without opioid dependence. | Chauchard E et al. | β | 2014 | β |
| Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement. | Litt MD et al. | β | 2013 | β |
| Cannabis withdrawal in chronic cannabis users with schizophrenia. | Boggs DL et al. | β | 2013 | β |
| Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. | Koola MM et al. | β | 2013 | β |
| Diagnostic criteria for cannabis withdrawal syndrome. | Gorelick DA et al. | β | 2012 | β |
| Understanding cannabis use in first-episode psychosis: an application of the Theory of Planned Behaviour. | Hames A et al. | β | 2012 | β |
| Marijuana dependence: not just smoke and mirrors. | Ramesh D et al. | β | 2011 | β |
| Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. | Ehlers CL et al. | β | 2010 | β |
| Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. | Preuss UW et al. | β | 2010 | β |
| Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. | Levin KH et al. | β | 2010 | β |
| Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project. | Buckner JD et al. | β | 2010 | β |
| Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. | Ehlers CL et al. | β | 2010 | β |
| Modeling withdrawal syndrome in zebrafish. | Cachat J et al. | β | 2010 | β |
| Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. | Copersino ML et al. | β | 2010 | β |
| Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. | Cooper ZD et al. | β | 2009 | β |
| Cannabis dependence as a primary drug use-related problem: the case for harm reduction-oriented treatment options. | Hathaway AD et al. | β | 2009 | β |
| Diaries from cannabis users: an interpretative phenomenological analysis. | Boserman C | β | 2009 | β |
| The adverse health effects of cannabis use: what are they, and what are their implications for policy? | Hall W | β | 2009 | β |
| Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. | Cooper ZD et al. | β | 2008 | β |
| Cannabis withdrawal in the United States: results from NESARC. | Hasin DS et al. | β | 2008 | β |
| Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. | Chung T et al. | β | 2008 | β |
| Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. | Nestor L et al. | β | 2008 | β |
| [Induced psychiatric and somatic disorders to cannabis]. | Laqueille X et al. | β | 2008 | β |
| Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? | Agrawal A et al. | β | 2008 | β |
| Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study. | Milin R et al. | β | 2008 | β |
| Use of dronabinol for cannabis dependence: two case reports and review. | Levin FR et al. | β | 2008 | β |
| Assessing addiction: concepts and instruments. | Samet S et al. | β | 2007 | β |
| Cannabis use and the mental health of young people. | Hall WD | β | 2006 | β |
| Cannabis withdrawal among non-treatment-seeking adult cannabis users. | Copersino ML et al. | β | 2006 | β |
| Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. | Zvolensky MJ et al. | β | 2006 | β |
| Peer influence and gender differences in problematic cannabis use among individuals with social anxiety. | Buckner JD et al. | β | 2006 | β |
| Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers. | Levin FR et al. | β | 2006 | β |
| Social anxiety and problematic cannabis use: evaluating the moderating role of stress reactivity and perceived coping. | Buckner JD et al. | β | 2006 | β |
| Social constructions of dependency by blunts smokers: Qualitative reports. | Dunlap E et al. | β | 2006 | β |
| The cannabis withdrawal syndrome. | Budney AJ et al. | β | 2006 | β |
| A cross-study comparison of cannabis and tobacco withdrawal. | Vandrey RG et al. | β | 2005 | β |
| Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. | Xu J et al. | β | 2005 | β |
| Cannabinoid tolerance and dependence. | Lichtman AH et al. | β | 2005 | β |
| Comorbidity: cannabis and complexity. | Raphael B et al. | β | 2005 | β |
| Human studies of cannabinoids and medicinal cannabis. | Robson P | β | 2005 | β |
| Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. | Seifert J et al. | β | 2005 | β |
| Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. | Aharonovich E et al. | β | 2005 | β |
| The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats. | Bortolato M et al. | β | 2005 | β |
| Adverse effects of cannabis on health: an update of the literature since 1996. | Kalant H | β | 2004 | β |
| Cannabis and psychopathology : update 2004. | Grover S et al. | β | 2004 | β |
| Review of the validity and significance of cannabis withdrawal syndrome. | Budney AJ et al. | β | 2004 | β |
| Role of endocannabinoid system in mental diseases. | Manzanares J et al. | β | 2004 | β |
| Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain. | Oliva JM et al. | β | 2004 | β |
| The endogenous cannabinoid system and the treatment of marijuana dependence. | Piomelli D | β | 2004 | β |
| Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. | Tanda G et al. | β | 2003 | β |
| The time course and significance of cannabis withdrawal. | Budney AJ et al. | β | 2003 | β |
| Adolescent substance abuse treatment: evidence-based practice in outpatient services. | Kaminer Y | β | 2002 | β |
| A review of the published literature into cannabis withdrawal symptoms in human users. | Smith NT | β | 2002 | β |
| Changing the focus: the case for recognizing and treating cannabis use disorders. | Dennis M et al. | β | 2002 | β |
| Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts. | Singleton EG et al. | β | 2002 | β |
| Effects of smoked marijuana in healthy and HIV + marijuana smokers. | Haney M | β | 2002 | β |
| Marijuana use among adolescents. | Gruber AJ et al. | β | 2002 | β |
| Marijuana withdrawal syndrome in the animal model. | Lichtman AH et al. | β | 2002 | β |
| The Marijuana Treatment Project: rationale, design and participant characteristics. | Stephens RS et al. | β | 2002 | β |
| Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. | Swift W et al. | β | 2001 | β |
| Correlates and 6-month outcomes for co-occurring cannabis use in rural and urban at-risk drinkers. | Booth BM et al. | β | 2001 | β |
| Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. | Cui SS et al. | β | 2001 | β |
| Psychiatric effects of cannabis. | Johns A | β | 2001 | β |
| Rages and refusals. Managing the many faces of adolescent anxiety. | Garland EJ | β | 2001 | β |
| Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice. | Valverde O et al. | β | 2000 | β |
| Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal. | Beardsley PM et al. | β | 2000 | β |
| Adverse effects of cannabis. | Hall W et al. | β | 1998 | β |
| Analysis of the medical use of marijuana and its societal implications. | Taylor HG | β | 1998 | β |
| Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. | RodrΓguez de Fonseca F et al. | β | 1997 | β |
| Marijuana addiction. | Grinspoon L et al. | β | 1997 | β |